Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy Regardless of PD-L1 Status in a Specific Type of Lung Cancer in Phase III Study
Go back to Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy Regardless of PD-L1 Status in a Specific Type of Lung Cancer in Phase III Study| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 50.35 +1.23 (2.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.12 | 52 Week High | $35.13 | |||
| Open | $50.10 | 52 Week Low | $28.10 | |||
| Day High | $50.48 | P/E | N/A | |||
| Day Low | $49.92 | EPS | $0.00 | |||
| Volume | 2,113,547 | |||||
| Brown & Brown, Inc. (NYSE: RO) | Delayed: 8.49 +0.55 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $8.59 | |||
| Open | $7.94 | 52 Week Low | $7.82 | |||
| Day High | $8.59 | P/E | 6.53 | |||
| Day Low | $7.82 | EPS | $1.30 | |||
| Volume | 42,732 | |||||
| ROGERS CORPORATION (NYSE: ROG) | Delayed: 159.14 -7.37 (4.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $166.51 | 52 Week High | $76.55 | |||
| Open | $160.21 | 52 Week Low | $41.92 | |||
| Day High | $163.98 | P/E | 89.91 | |||
| Day Low | $158.68 | EPS | $1.77 | |||
| Volume | 316,740 | |||||
